Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

12 results about "Cerebral circulation" patented technology

Cerebral circulation is the movement of blood through the network of cerebral arteries and veins supplying the brain. The rate of the cerebral blood flow in the adult is typically 750 milliliters per minute, representing 15% of the cardiac output. The arteries deliver oxygenated blood, glucose and other nutrients to the brain, and the veins carry deoxygenated blood back to the heart, removing carbon dioxide, lactic acid, and other metabolic products.

Thaflavin composition for treating hypertension as well as preparation method and application of theaflavin composition

The invention provides a theaflavin composition for treating hypertension as well as a preparation method and application thereof, and relates to the technical field of medicines. The theaflavin composition comprises theaflavin, a celery seed extract, a gastrodia elata extract, a parasitic loranthus extract, a centella asiatica extract, a lotus leaf extract and a licorice extract. Wherein the theaflavin can regulate blood fat, inhibit atherosclerosis and improve the vascular endothelial function; the celery seed extract inhibits the activity of angiotensin converting enzyme, and cooperates with theaflavin to regulate blood pressure; the gastrodia elata extract can calm liver wind and improve cerebral circulation; the loranthus parasiticus extract has the effects of tonifying liver and kidney and regulating water sodium metabolism; the centella asiatica extract can resist inflammation and repair vascular endothelium; the lotus leaf extract can clear heat, promote diuresis, calm the liver and suppress yang; and the licorice extract harmonizes the medicines and resists oxidation. According to the invention, theaflavin is taken as a core, multi-dimensional effects of reducing blood pressure, protecting blood vessels and resisting inflammation and oxidation are realized, and a natural and comprehensive health management scheme is provided for hypertensive patients.
Owner:NANTONG TEANOL BIOTECHNOLOGY CO LTD

Pharmaceutical composition for treating Alzheimer's disease and preparation and detection methods thereof

The invention provides a pharmaceutical composition for treating Alzheimer's disease. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 10-15 parts of ginseng, 10-15 parts of rhizoma acori graminei, 10-15 parts of polygala tenuifolia, 15-20 parts of rhizoma polygonati, 15-20 parts of ginkgo leaves and 5-10 parts of schisandra chinensis. Therefore, the ginseng and the ginkgo leaves jointly regulate a cholinergic system and cerebral blood flow, and the cognitive function is enhanced; the rhizoma acori graminei and the ginkgo leaves cooperate to inhibit aggregation of beta-amyloid protein, improve cerebral circulation and relieve neurotoxicity. Polygonatum sibiricum and Chinese magnoliavine fruit protect nerve cells through anti-oxidation and anti-inflammatory effects and reduce nerve injury. Schizandrin further stabilizes a neurotransmitter system and enhances the synergistic effect of other medicinal materials, a multi-layer treatment network of Abeta deposition inhibition, cholinergic system regulation, anti-inflammation and anti-oxidation and nerve protection is integrally formed, and the core pathological link of the Alzheimer's disease is comprehensively intervened, so that the cognitive function is improved, and the disease progress is delayed.
Owner:SHAANXI XIZHOU PHARM CO LTD

Protein powder for assisting in improving Alzheimer's disease and preparation method thereof

The invention belongs to the technical field of food nutrition and health, and particularly discloses protein powder for assisting in improving Alzheimer's disease and a preparation method of the protein powder according to the concept of dietary therapy in China, and the protein powder is prepared from the following components in percentage by weight: 35-45% of egg white protein peptide powder and 55-65% of core function compound powder. According to the invention, egg white protein peptide is used as a high-quality matrix, and nine specific medicinal materials including hippocampus, egg yolk phospholipid, egg membrane peptide, walnut, fructus alpiniae oxyphyllae, gastrodia elata, mulberry, sargassum fusiforme, wolfberry, ginkgo leaf, fructus evodiae and dandelion are cooperatively compatible; aiming at seven core pathological links of Alzheimer's disease, such as A beta deposition, Tauopathy, neuroinflammation, oxidative stress, cholinergic deficiency, neurodystrophy and cerebral circulation disorder, a multi-target synergistic effect network is constructed, comprehensive neuroprotection is realized, and tests prove that the space learning and memory ability and the autonomous activity ability can be effectively improved.
Owner:HEFEI UNIV OF TECH

Intelligent hypertension health management system

The invention, which relates to the medical health management field, discloses an intelligent hypertension health management system comprising a data acquisition module, a data processing module, an early warning module and an interaction module. By constructing the cerebral circulation-blood pressure association model, the potential association relationship between the cerebral hemodynamic parameters and the blood pressure data can be accurately mined, so that the possibility of blood pressure abnormality caused by cerebral vasculopathy is effectively judged, and when abnormality is detected, the system can send out an early warning signal in time, so that the early warning effect is improved. And according to the abnormal degree and the historical health data of the user, customized health suggestions are provided for the user through a personalized health suggestion generation algorithm, and the combination of the precise early warning and the personalized health suggestions helps the user to timely discover and process potential health problems and improve the health management effect.
Owner:NAT CENT FOR CHRONIC & NONCOMMUNICABLE DISEASE CONTROL & PREVENTION CHINESE CENT FOR DISEASE CONTROL & PREVENTION

Cerebral circulation function therapeutic apparatus convenient to carry

ActiveCN223696019USurgical furnitureArtificial respirationPhysical therapyCerebral circulation
The utility model discloses a brain circulation function therapeutic instrument convenient to carry, which comprises a box body, one side of the box body is rotatably connected with a box cover, the other side of the box body is provided with an opening and closing buckle, two side walls of an inner cavity of the box body are provided with a limiting plate, a placing box, a fixing assembly and a control instrument, and the top of the box body is provided with a spring groove and a buckle assembly. An electric telescopic rod, a bearing block and a treatment cap are arranged at the bottom of an inner cavity of the box body, a handle is arranged on one side of the box cover, and straps are arranged on the side wall of the box body. According to the brain circulation function therapeutic instrument convenient to carry, the control instrument can be fixed in the inner cavity of the containing box through the fixing assembly, the therapeutic cap is clamped on the bearing block, the therapeutic instrument can be fixed in the inner cavity of the box body, the containing box is fixed through the buckle assembly, the therapeutic instrument is prevented from being damaged when the box body is moved, and the therapeutic instrument is convenient to carry. The box body and the box cover can be fixed conveniently through the opening and closing buckles, the box body can be carried on the back through the straps, and carrying is convenient.
Owner:XUZHOU KEJIAN HI TECH

Double-vine dizziness-relieving decoction for relieving Parkinson's disease and preparation method of double-vine dizziness-relieving decoction

The invention relates to the technical field of traditional Chinese medicine preparations, in particular to a radix euonymi and caulis spatholobi dizziness relieving decoction for relieving Parkinson's disease, and the radix euonymi and caulis spatholobi dizziness relieving decoction comprises euonymus fortunei, caulis spatholobi, radix paeoniae alba, radix polygoni multiflori preparata, glossy privet fruit, radix fici simplicissimae, gastrodia elata and ramulus uncariae cum uncis. Compared with the prior art, the traditional Chinese medicine composition treats both symptoms and root causes through a multi-way synergistic effect, and has the effects of treating liver-kidney deficiency, liver-yang hyperactivity, deficiency wind internal movement and meridian stasis. The modern pharmacological basis mainly relates to the effects of calming, resisting convulsion, reducing blood pressure, improving brain circulation, promoting hematopoiesis, resisting oxidation, resisting platelet aggregation, regulating immunity, relieving spasm and the like, can be used for improving mitochondrial function damage and protein expression of mitochondrial function related protein PGC-1alpha, can be used for improving PD tyrosine hydroxylase expression and reducing abnormal aggregation of alpha-syn, and can be used for treating the mitochondrial function damage and the mitochondrial function related protein PGC-1alpha. Therefore, neurons are protected, and PD pathological conditions are improved.
Owner:GUANGXI INT ZHUANG MEDICINE HOSPITAL

Embolic protection access system

PendingCN121081167AMulti-lumen catheterHeart valvesBrain vasculatureGreat Blood Vessel
Methods and devices are provided for protecting cerebrovascular circulation from embolic fragments released during indexed surgery. The embolic protection filter is delivered in a reduced profile configuration via the access catheter and positioned on the aorta across the three major vascular openings leading to the cerebral circulation. Thereafter, the indexing surgical catheter is advanced through the same access catheter to perform indexing surgery. The indexing procedure may be transcatheter aortic valve replacement.
Owner:ENCOMPASS TECHNOLOGIES INC

Movable cerebral circulation treatment device

The utility model belongs to the technical field of medical instruments, and particularly relates to a movable cerebral circulation treatment device which comprises a moving device, the moving device comprises a seat cushion, the front end of the seat cushion is fixedly connected with a leg support, the side edge of the seat cushion is fixedly connected with a handrail handle, the side edge of the seat cushion is fixedly connected with a backrest, and the backrest is fixedly connected with a connecting rod. The bottom of the cushion is fixedly connected with a round base, one end of the round base is fixedly connected with a hydraulic telescopic rod, the hydraulic telescopic rod is arranged on a supporting leg in a sleeving mode, self-locking universal wheels are distributed and installed on the circumference of the supporting leg, one end of the round base is fixedly connected with a connecting rod, and the bottom of the connecting rod is fixedly connected with an installation block. The multi-dimensional adjusting structure of the treatment cap comprises an electric push rod, multi-stage rotating connection and horizontal and vertical rotation of a shaft piece, so that the treatment cap can be accurately aligned to the treatment part of the head of a patient, the treatment cap is suitable for individual differences of different patients, and the treatment effect is improved.
Owner:HEFEI FOURTH PEOPLES HOSPITAL

Brain circulation time measuring method and device, terminal and storage medium

The invention provides a brain circulation time measuring method and device, a terminal and a storage medium, and belongs to the technical field of data information processing, and the method comprises the steps that a target file is acquired, and the target file comprises internal carotid artery time-intensity curve data and jugular vein time-intensity curve data after a user carries out intravenous injection of an ultrasonic contrast agent; determining a moment when the signal intensity of the internal carotid artery reaches 10% of the signal amplitude for the first time as a first time point; determining a moment when the signal intensity of the jugular vein reaches 10% of the signal amplitude for the first time as a second time point; and obtaining the brain circulation time based on the first time point and the second time point. By automatically processing the time-intensity curve data of the internal carotid artery and the jugular vein, the first time point and the second time point can be effectively identified, the cerebral circulation time is automatically calculated based on the two time points, and the accuracy and efficiency of cerebral circulation time measurement can be effectively improved.
Owner:SHENZHEN PEOPLES HOSPITAL

Multi-mode stimulation device for promoting cerebral circulation

The utility model provides a multi-mode stimulation device for promoting cerebral circulation, and aims to solve the problem of poor cerebral circulation improvement effect caused by single stimulation mode of equipment for promoting cerebral circulation in the prior art. A multi-mode stimulation device for promoting cerebral circulation comprises a glasses assembly which comprises a glasses frame and two glasses legs located on the left side and the right side of the glasses frame respectively, and the glasses frame is provided with two sets of LED lamp assemblies which correspond to the left eye and the right eye of a person respectively and emit light at the frequency of 40 HZ; the nose plug assembly comprises a mounting seat electrically connected with the glasses legs and two nose plugs arranged on the mounting seat, and a near-infrared lamp emitting light at the frequency of 40HZ is arranged in each nose plug; the earplug assembly comprises two earplugs capable of producing sound at the frequency of 40HZ, and the two earplugs are respectively arranged on the two glasses legs. According to the invention, through photoacoustic multi-mode synergistic stimulation, the effect of better improving the cerebral blood perfusion function can be achieved, so that the cerebral function is improved.
Owner:HANGZHOU SHUDAN MEDICAL TECH CO LTD

Intelligent state analysis method for anesthetized patients based on physiological data

PendingCN122369983APerfusionInternalization
This invention discloses an intelligent state analysis method for anesthetized patients based on physiological data, comprising the following steps: S1, organizing and annotating historical anesthesia data to form executable state recognition rules and establishing a standardized historical case reference library. The beneficial effects of this invention are: by decomposing key interactive substructures such as nerve-circulation, brain-circulation, and respiration-perfusion from dynamic network profiles, coordinating indicators with clear physiological significance, such as baroreflex function index, brain oxygen-blood pressure coupling coefficient, and ventilation-perfusion matching degree, are calculated; these indicators can quantify the coordination of physiological systems under anesthesia from multiple dimensions; the system performs multi-dimensional similarity matching of these real-time indicators with an internalized anesthesia state knowledge base (containing multiple preset state modes), realizing accurate and interpretable independent determination of the anesthesia depth state in three dimensions: sedation, analgesia, and muscle relaxation, overcoming the limitations of traditional single index monitoring.
Owner:HANGZHOU CHILDRENS HOSPITAL

Cerebral circulation dysfunction therapeutic apparatus and control method thereof

The invention relates to the technical field of therapeutic apparatuses, in particular to a cerebral circulation dysfunction therapeutic apparatus and a control method thereof.The cerebral circulation dysfunction therapeutic apparatus comprises a therapeutic cap and a therapeutic assembly, and the therapeutic assembly comprises an electroencephalogram collection module, a near-infrared blood oxygen monitoring module, a far-infrared thermal therapy module, an electrical stimulation module, a magnetic stimulation module and a control host; a patient wears the treatment cap on the head, the electroencephalogram collection module collects electroencephalogram frequency spectrum indexes, and the near-infrared blood oxygen monitoring module collects regional blood oxygen indexes; based on the collected electroencephalogram frequency spectrum indexes and regional blood oxygen indexes, the control host judges electroencephalogram and regional blood oxygen states; the control host outputs a corresponding treatment mode according to the electroencephalogram and the regional blood oxygen state, and controls the far infrared thermal therapy module, the electrical stimulation module and the magnetic stimulation module to be started to treat a patient; the rehabilitation efficiency of cerebral circulation dysfunction can be improved.
Owner:GUILIN WANDOM MEDICAL APP CO LTD